Aterian Investment Partners has closed on Contract Pharmaceuticals Limited, our 13th investment in life sciences, personal care, and nutrition! Excited to invest in people, technology, and processes to grow the business and create value for customers, the end-user and all stakeholders. #privateequity #mergersandacquisitions #pharmaceutical #CDMO
Aterian Investment Partners
Venture Capital and Private Equity Principals
New York, NY 1,963 followers
We invest in personal connections with our management teams. From there, we drive optimal outcomes together.
About us
Aterian Investment Partners is a private equity firm that invests in industry-leading, middle market businesses. In collaboration with management, Aterian supports investments throughout an organization, from people to processes, equipment, technology, and social governance, among others. With offices in New York and Florida, Aterian has raised cumulative equity commitments of more than $1.5 billion since its founding in 2009.
- Website
-
http://www.aterianpartners.com
External link for Aterian Investment Partners
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2009
Locations
-
Primary
Get directions
550 Fifth Avenue
8th Floor
New York, NY 10036, US
-
Get directions
135 San Lorenzo Avenue
Suite 790
Coral Gables, FL 33146, US
Employees at Aterian Investment Partners
Updates
-
Aterian Investment Partners is pleased to announce Jay Taunk has joined the investment team as a Principal in our Miami office. Jay brings a wealth of experience and expertise, particularly in the chemicals space. Welcome to the team!
-
Excited to announce Aterian Investment Partners has entered into an agreement to recapitalize Contract Pharmaceuticals Limited! CPL is a leading provider of development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical products globally. #privateequity #mergersandacquisitions #pharmaceutical #CDMO
Aterian Investment Partners’ third healthcare manufacturing and first Canadian platform! Pumped to share Aterian has entered into an agreement to recapitalize Contract Pharmaceuticals Limited, a leading pharmaceutical contract development & manufacturing organization (CDMO). CPL provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical products. #privateequity #mergersandacquisitions #pharmaceutical #CDMO
-
A worthwhile quick watch. Here Aterian Investment Partners discusses important topics, in particular supporting our veterans.
What does it take to be an excellent Middle Market Private Equity business developer? Recently, I had the great pleasure to speak with Christian Remmel about his early learnings and experiences that have helped him become a stellar originator and BD professional in any market environment. Christian has been a proactive member of the ACG New York chapter and sits on the chapter advisory board, as well as a number of committees including our Veterans In Middle Market network. Here Christian explains the aims of the network and why the VMM innitiative is something worth extending across all Association for Corporate Growth (ACG) chapters. #privateequity #middlemarket #businessdevelopment #veteranssupport
-
Aterian Investment Partners is pleased to announce the closing of its ~$460M Continuation Vehicle for Vander-Bend Manufacturing in September. Vander-Bend specializes in precision machining of capital equipment and consumables for the medical technology end markets. Thank you to all the new and existing investors for their support in the growth and development of Vander-Bend! https://lnkd.in/eKw4bREV #privateequity #medtech #healthcare
Aterian Investment Partners Closes ~$460 Million Continuation Vehicle for Vander-Bend Manufacturing
prnewswire.com